世界のがん治療における感染管理市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC14712)
◆英語タイトル:Global Infection Control in Cancer Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC14712
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:機械・機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、がん治療における感染管理の世界市場を調査対象にし、がん治療における感染管理の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(放射線療法、免疫療法、トラディショナル手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他)、用途別分析(病院、製薬会社、医療機器会社、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Kimberly Clark Corporation、Nordion、Getinge Group AB、3M Healthcare Company、Arizant Healthcare Inc.、Honeywell International, Inc.、Steris Corporation、Sakura Global Holding Company、Sterigenics International、Cisa S.P.A.、Advanced Sterilization Products Services, Inc、Nordion, Inc.、Synergy Health, Plc、Ahlstrom Filtration LLC、Membrana GmbH
・企業別売上、市場シェア
・がん治療における感染管理の地域別市場分析
・がん治療における感染管理の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・がん治療における感染管理のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・がん治療における感染管理のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・がん治療における感染管理の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・がん治療における感染管理の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・がん治療における感染管理の種類別市場規模2015-2020:放射線療法、免疫療法、トラディショナル手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他
・がん治療における感染管理の用途別市場規模2015-2020:病院、製薬会社、医療機器会社、その他
・がん治療における感染管理の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Infection Control in Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Infection Control in Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Infection Control in Cancer Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Infection Control in Cancer Therapy market has been segmented into:
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other

By Application, Infection Control in Cancer Therapy has been segmented into:
Hospital
Pharmaceutical Companies
Medical device companies
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infection Control in Cancer Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Infection Control in Cancer Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infection Control in Cancer Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Infection Control in Cancer Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Infection Control in Cancer Therapy Market Share Analysis
Infection Control in Cancer Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infection Control in Cancer Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infection Control in Cancer Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Infection Control in Cancer Therapy are:
Kimberly Clark Corporation
Nordion
Getinge Group AB
3M Healthcare Company
Arizant Healthcare Inc.
Honeywell International, Inc.
Steris Corporation
Sakura Global Holding Company
Sterigenics International
Cisa S.P.A.
Advanced Sterilization Products Services, Inc
Nordion, Inc.
Synergy Health, Plc
Ahlstrom Filtration LLC
Membrana GmbH

【レポートの目次】

1 Infection Control in Cancer Therapy Market Overview
1.1 Product Overview and Scope of Infection Control in Cancer Therapy
1.2 Classification of Infection Control in Cancer Therapy by Type
1.2.1 Global Infection Control in Cancer Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infection Control in Cancer Therapy Revenue Market Share by Type in 2019
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Traditional Surgery
1.2.6 Stem Cell Transplant Therapy
1.2.7 Chemotherapy
1.2.8 Targeted Therapy
1.2.9 Photodynamic Therapy
1.2.10 Other
1.3 Global Infection Control in Cancer Therapy Market by Application
1.3.1 Overview: Global Infection Control in Cancer Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Medical device companies
1.3.5 Other
1.4 Global Infection Control in Cancer Therapy Market by Regions
1.4.1 Global Infection Control in Cancer Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infection Control in Cancer Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Kimberly Clark Corporation
2.1.1 Kimberly Clark Corporation Details
2.1.2 Kimberly Clark Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Kimberly Clark Corporation SWOT Analysis
2.1.4 Kimberly Clark Corporation Product and Services
2.1.5 Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nordion
2.2.1 Nordion Details
2.2.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nordion SWOT Analysis
2.2.4 Nordion Product and Services
2.2.5 Nordion Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Getinge Group AB
2.3.1 Getinge Group AB Details
2.3.2 Getinge Group AB Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Getinge Group AB SWOT Analysis
2.3.4 Getinge Group AB Product and Services
2.3.5 Getinge Group AB Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 3M Healthcare Company
2.4.1 3M Healthcare Company Details
2.4.2 3M Healthcare Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 3M Healthcare Company SWOT Analysis
2.4.4 3M Healthcare Company Product and Services
2.4.5 3M Healthcare Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Arizant Healthcare Inc.
2.5.1 Arizant Healthcare Inc. Details
2.5.2 Arizant Healthcare Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Arizant Healthcare Inc. SWOT Analysis
2.5.4 Arizant Healthcare Inc. Product and Services
2.5.5 Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Honeywell International, Inc.
2.6.1 Honeywell International, Inc. Details
2.6.2 Honeywell International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Honeywell International, Inc. SWOT Analysis
2.6.4 Honeywell International, Inc. Product and Services
2.6.5 Honeywell International, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Steris Corporation
2.7.1 Steris Corporation Details
2.7.2 Steris Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Steris Corporation SWOT Analysis
2.7.4 Steris Corporation Product and Services
2.7.5 Steris Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sakura Global Holding Company
2.8.1 Sakura Global Holding Company Details
2.8.2 Sakura Global Holding Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sakura Global Holding Company SWOT Analysis
2.8.4 Sakura Global Holding Company Product and Services
2.8.5 Sakura Global Holding Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sterigenics International
2.9.1 Sterigenics International Details
2.9.2 Sterigenics International Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sterigenics International SWOT Analysis
2.9.4 Sterigenics International Product and Services
2.9.5 Sterigenics International Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cisa S.P.A.
2.10.1 Cisa S.P.A. Details
2.10.2 Cisa S.P.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cisa S.P.A. SWOT Analysis
2.10.4 Cisa S.P.A. Product and Services
2.10.5 Cisa S.P.A. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Advanced Sterilization Products Services, Inc
2.11.1 Advanced Sterilization Products Services, Inc Details
2.11.2 Advanced Sterilization Products Services, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Advanced Sterilization Products Services, Inc SWOT Analysis
2.11.4 Advanced Sterilization Products Services, Inc Product and Services
2.11.5 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Nordion, Inc.
2.12.1 Nordion, Inc. Details
2.12.2 Nordion, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Nordion, Inc. SWOT Analysis
2.12.4 Nordion, Inc. Product and Services
2.12.5 Nordion, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Synergy Health, Plc
2.13.1 Synergy Health, Plc Details
2.13.2 Synergy Health, Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Synergy Health, Plc SWOT Analysis
2.13.4 Synergy Health, Plc Product and Services
2.13.5 Synergy Health, Plc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ahlstrom Filtration LLC
2.14.1 Ahlstrom Filtration LLC Details
2.14.2 Ahlstrom Filtration LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ahlstrom Filtration LLC SWOT Analysis
2.14.4 Ahlstrom Filtration LLC Product and Services
2.14.5 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Membrana GmbH
2.15.1 Membrana GmbH Details
2.15.2 Membrana GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Membrana GmbH SWOT Analysis
2.15.4 Membrana GmbH Product and Services
2.15.5 Membrana GmbH Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infection Control in Cancer Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infection Control in Cancer Therapy Players Market Share
3.2.2 Top 10 Infection Control in Cancer Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Regions
4.2 North America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5 North America Infection Control in Cancer Therapy Revenue by Countries
5.1 North America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
5.2 USA Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6 Europe Infection Control in Cancer Therapy Revenue by Countries
6.1 Europe Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
6.2 Germany Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.4 France Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries
7.1 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
7.2 China Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.5 India Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
8 South America Infection Control in Cancer Therapy Revenue by Countries
8.1 South America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
8.2 Brazil Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infection Control in Cancer Therapy by Countries
9.1 Middle East & Africa Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Infection Control in Cancer Therapy Market Forecast by Type (2019-2024)
10.3 Radiation Therapy Revenue Growth Rate (2015-2025)
10.4 Immunotherapy Revenue Growth Rate (2015-2025)
10.5 Traditional Surgery Revenue Growth Rate (2015-2025)
10.6 Stem Cell Transplant Therapy Revenue Growth Rate (2015-2025)
10.7 Chemotherapy Revenue Growth Rate (2015-2025)
10.8 Targeted Therapy Revenue Growth Rate (2015-2025)
10.9 Photodynamic Therapy Revenue Growth Rate (2015-2025)
10.10 Other Revenue Growth Rate (2015-2025)
11 Global Infection Control in Cancer Therapy Market Segment by Application
11.1 Global Infection Control in Cancer Therapy Revenue Market Share by Application (2015-2020)
11.2 Infection Control in Cancer Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Medical device companies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Infection Control in Cancer Therapy Market Size Forecast (2021-2025)
12.1 Global Infection Control in Cancer Therapy Market Size Forecast (2021-2025)
12.2 Global Infection Control in Cancer Therapy Market Forecast by Regions (2021-2025)
12.3 North America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.6 South America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがん治療における感染管理市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Infection Control in Cancer Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。